Qiming Venture Partners

Developer of artificial meat. The company develops artificial meat and cultured alternative protein products at the cellular level, committing to creating a new solution for future food supply.

Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Shanghai Biotree Biotech Co., Ltd. specializes in the development and application of life science research technologies. Founded in 2013, the company is based in Shanghai, China, and focuses on sample testing, big data analysis, and technical product development within the life sciences sector. It offers a range of professional services tailored to universities, research institutes, hospitals, and enterprises. Biotree is particularly noted for its expertise in metabolomics, providing early detection and analysis services, as well as consulting related to mass spectrometry and metabolic testing. The company has a strong portfolio of patents in metabolomics and continues to innovate in product development and technology within this field. Since its inception, Biotree has demonstrated consistent growth and profitability, establishing itself as a key player in the domestic metabolomics detection and analysis market.

AskGene Pharma is a biotechnology firm. It is developing novel cytokine prodrugs to address critical unmet medical needs in oncology and autoimmune disease. It is unlocking the full therapeutic potential of cytokine molecules with their innovative smart kine prodrug platform. It overcomes a number of significant challenges, providing a clear pathway to a range of next-generation cytokine therapies. They provide safer and better medicines for saving patients’ lives. They are equipped with the most advanced R&D facilities.

ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed. Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost and programmable platform, offering a wide range of possibilities in chemistry, biology and medtech.

GluBio Pharmaceutical focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

GenEdit Inc. is a biotechnology company based in Berkeley, California, established in 2016. It specializes in developing innovative genome editing technologies, particularly using the CRISPR/Cas9 system for therapeutic gene editing. The company focuses on addressing the challenges associated with the delivery of gene therapies through its proprietary non-viral nanoparticle-based delivery platform. This platform enables more efficient and accurate delivery of CRISPR components, enhancing the potential for curative treatments for genetic diseases. By systematically screening a library of nanoparticles, GenEdit aims to improve the safety and effectiveness of gene editing, making it a promising solution for a wide range of therapeutic applications.

Atom Semiconductor is a scientific and technological enterprise focusing on digital sensor design. Atom Semiconductor was founded in 2020.

Developer of Tumor-treating Fields technology. The company's products are focused on delivering diagnostic and minimally invasive treatment tools for various brain cancers, enabling healthcare professionals to more effectively treat patients.

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.

Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

Eigen is applying the latest AI technologies to variety of business domains, making AI the center of thegravity in industrial evolutions.

CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

AI-Prime is a company based in Shanghai, China, that specializes in artificial intelligence-driven safety solutions for industrial environments. It offers a cloud-based software-as-a-service platform that integrates with camera systems to enhance workplace safety. The company's technology focuses on identifying direct threats and provides data-driven insights and reports that facilitate a continuous feedback loop. This approach enables various industries to automate safety measures and improve operational efficiency. AI-Prime's commitment to creating safer working environments positions it as a key player in the field of industrial security solutions.

ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Eigen is applying the latest AI technologies to variety of business domains, making AI the center of thegravity in industrial evolutions.

Gaiya Environment is a scientific and innovative enterprise specializing in independent research and development of soil remediation technology and equipment. Based on the industrialization and application of scientific research results and the core of independent technological innovation, the company adheres to the strategy of providing customers with one-stop solutions from front-end field to back-end repair through national network layout. Gaiya Environment was founded in 2012 and is based in Suzhou in Jiangsu, China.

SGEET is a high-tech enterprise that specializes in the disposal of organic waste and the remediation of contaminated sites.

Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

CETA is an environmental test and analysis company.

Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Supplier of analytical software trading tools intended to provide accurate, real-time market data. The company's technical analysis and fundamental information tool enables most energy companies and large agricultural trading firms to manage, filter and quickly analyze pricing, trends and news, that is crucial to making informed and profitable trading decisions. It also provides server and middleware tools, as well as a rich set of web services for customers integrating financial information and analysis of their enterprise-wide systems.

Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.

Ants Technology

Ants Technology

Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.

Alltech Medical Systems is a Chinese company that specializes in medical imaging technologies and solutions, particularly in the development of magnetic resonance imaging (MRI) systems and other advanced diagnostic equipment. Its primary operational hubs are located in Cleveland, USA, and Chengdu, China. The company offers a range of products, including a 1.5 T magnetic resonance system that features a multichannel data acquisition system for real-time imaging and advanced RF coils. These innovations support a variety of clinical applications and incorporate intelligent graphical user interfaces for streamlined scanning workflows. Alltech Medical Systems also develops other imaging technologies such as X-ray computed tomography, digital X-ray systems, color Doppler ultrasound, and PET-MR. With a management and technology team comprised of professionals with extensive experience in medical imaging, the company has secured over 100 international patents in the field. It aims to enhance medical imaging services in hospitals across China by integrating Internet and artificial intelligence technologies into its offerings.

Alltech Medical Systems is a Chinese company that specializes in medical imaging technologies and solutions, particularly in the development of magnetic resonance imaging (MRI) systems and other advanced diagnostic equipment. Its primary operational hubs are located in Cleveland, USA, and Chengdu, China. The company offers a range of products, including a 1.5 T magnetic resonance system that features a multichannel data acquisition system for real-time imaging and advanced RF coils. These innovations support a variety of clinical applications and incorporate intelligent graphical user interfaces for streamlined scanning workflows. Alltech Medical Systems also develops other imaging technologies such as X-ray computed tomography, digital X-ray systems, color Doppler ultrasound, and PET-MR. With a management and technology team comprised of professionals with extensive experience in medical imaging, the company has secured over 100 international patents in the field. It aims to enhance medical imaging services in hospitals across China by integrating Internet and artificial intelligence technologies into its offerings.